alexa Venkateswarlu Chamcha | University of Louisiana
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Venkateswarlu Chamcha

Venkateswarlu Chamcha Venkateswarlu Chamcha
University  of Louisiana

Dr. Venkateswarlu Chamcha trained as molecular virologist at National Institute of Virology, India and received a PhD degree for developing a vaccine for Chandipura viral encephalitis disease in 2010. He has very good knowledge in developing vaccines for various viral diseases and testing or conducting various vaccine trials in animal models such as Mice, Rabbits, Guinea pigs and in Rhesus macaques. Being a postdoctoral fellow at Emory University's Yerkes National Primate Research Center since 2010, he is working extensively on HIV vaccine development by using a probiotics organism i.e. lactococcus lactis. This vaccine modality is one of the novel approaches and gave very interesting results and Dr. Chamcha is one of the key people in developing this project. His studies in mice and Nonhuman primates demonstrated that a recombinant L.lactis generates good vaccine specific immune responses targeted mainly in the gut of these animals. Other aspects of his studies involved are conducting some efficacy studies using DNA prime and MVA boost vaccine modalities and understanding the immune correlates of these vaccine mediated immunity and protection to SIV infection. Currently these vaccine modalities have been tested in human clinical trials for HIV vaccine in USA.

Research Interest

HIV/SIV vaccine development, Understanding the mucosal immunity to Vaccines, Developing probiotic bacteria as a vaccine vector for viral diseases, Modulating the immune responses in the GALT to HIV vaccines


Global Speakers in the subject

Global Experts in the subject


Current Scenario and Future Prospects of HIV Vaccines
Editor Note: J AIDS Clin Res 2016, 7: e125
DOI: 10.4172/2155-6113.1000e125
Advancements of HIV/AIDS Treatment, Socio-Economic Impact, and the Impact of the HIV Co-infections
Venkateswarlu Chamcha
Editor Note: J AIDS Clin Res 2016, 7: e124
DOI: 10.4172/2155-6113.1000e124
Editor Note
Venkateswarlu Chamcha
Editor Note: J AIDS Clin Res 2016, 7: e120
DOI: 10.4172/2155-6113.1000e120
Probiotics Based Approaches to Target Mucosal Compartments: Potential Novel Approaches to HIV Vaccine Development
Venkateswarlu Chamcha
Editorial: J AIDS Clin Res 2016, 7: e119
DOI: 10.4172/2155-6113.1000e119
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version